[1] Ghosh A,Malty PK,Hemashettar BM,et al.Physiological characters of Sporothrix schenckii isolates[J].Mycoses,2002,45(11-12):449-454. [2] Da Rosa D,Gezuele E,Calegari L,et al.Excretion-secretion products and proteases from live Sporothrix schenckii yeast phase:immunological detoction and cleavage of human IgG[J].Rev Inst Med Trpp Sao Paulo,2009,51(1):1-7. [3] Trilles L,Fernandez-Tortes B,Dos Santos Lazera M,et al.In vitro antifungal susceptibilities of Sporothrix schenckii in two growth phases[J].Antimicrob Agents Chemother,2005,49(9):3952-3954. [4] Kohler LM,Monteiro PC,Hahn RC,et al.In vitro susceptibilities of isolates of Sporothrix schenckii to itraconazole and terbinafine[J].J Clin Microbiol,2004,42(9):4319-4320. [5] Northey WT,Brooks LD.In vitro conversion of Histoplasma capsulatum[J].J Bacteriol,1962,84:577-580. [6] Pine L,Peacock CL.Studies on the growth of Histoplasmacapsulatum.Ⅳ.Factors influencing conversion of the mycelial phase to the yeast phase[J].J Bacterial,1958,75(2):167-174. [7] Hempel H,Goodman NL.Rapid conversion of Histoplasma capsulatum,Blastomyces dermatitidis and Sporothrix schenckii in tissue culture[J].J Clin Microbiol,1975,1(5):420-424. [8] Dixon DM,Salkin IF,Duncan RA,et al.Isolation and characterization of Sporothrix schenckii from clinical and environmental sources associated with the largest U.S.epidemic of sporotrichosis[J].J Clin Microbiol,1991,29(6):1106-1113. |